Solventum (NYSE:SOLV) and Alpha Tau Medical (NASDAQ:DRTS) Head to Head Review

Alpha Tau Medical (NASDAQ:DRTSGet Free Report) and Solventum (NYSE:SOLVGet Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, earnings, risk, profitability and valuation.

Profitability

This table compares Alpha Tau Medical and Solventum’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Alpha Tau Medical N/A -38.62% -29.89%
Solventum N/A N/A N/A

Earnings and Valuation

This table compares Alpha Tau Medical and Solventum”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Alpha Tau Medical N/A N/A -$29.16 million ($0.43) -7.79
Solventum $8.26 billion 1.45 N/A N/A N/A

Solventum has higher revenue and earnings than Alpha Tau Medical.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Alpha Tau Medical and Solventum, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical 0 0 2 0 3.00
Solventum 1 9 1 0 2.00

Alpha Tau Medical presently has a consensus target price of $8.00, indicating a potential upside of 138.81%. Solventum has a consensus target price of $68.29, indicating a potential downside of 1.69%. Given Alpha Tau Medical’s stronger consensus rating and higher possible upside, equities analysts plainly believe Alpha Tau Medical is more favorable than Solventum.

Institutional and Insider Ownership

2.7% of Alpha Tau Medical shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Alpha Tau Medical beats Solventum on 5 of the 8 factors compared between the two stocks.

About Alpha Tau Medical

(Get Free Report)

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

About Solventum

(Get Free Report)

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.